Nymox Pharmaceutical
NYMX
#10189
Rank
A$27.47 M
Marketcap
Country
A$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : A$4.73 Million

According to Nymox Pharmaceutical's latest financial reports the company's total liabilities are A$4.73 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nymox Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$3.09 M15.17%
2021-12-31A$2.68 M-5.95%
2020-12-31A$2.85 M-1.94%
2019-12-31A$2.91 M91.21%
2018-12-31A$1.52 M-46.63%
2017-12-31A$2.85 M-23.7%
2016-12-31A$3.74 M-21.29%
2015-12-31A$4.75 M-30.53%
2014-12-31A$6.84 M-13.06%
2013-12-31A$7.87 M-11.03%
2012-12-31A$8.85 M-21.57%
2011-12-31A$11.28 M-29.91%
2010-12-31A$16.1 M468.92%
2009-12-31A$2.83 M58.88%
2008-12-31A$1.78 M20.3%
2007-12-31A$1.48 M-45.56%
2006-12-31A$2.72 M-20.61%
2005-12-31A$3.42 M29.1%
2004-12-31A$2.65 M14.41%
2003-12-31A$2.31 M-11.2%
2002-12-31A$2.61 M78.35%
2001-12-31A$1.46 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Abbott Laboratories
ABT
A$49.55 B 1,045,548.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.08 B 3,673,184.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$13.28 B 280,109.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$137.12 B 2,893,311.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 3,606,602.67%๐Ÿ‡บ๐Ÿ‡ธ USA